(Q42808224)

7 November 2017

Functional and Immunological Characterization of SIV Envelope Glycoprotein Produced in Genetically Engineered Mammalian Cells (English)

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

17 November 2022

0 references

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

17 November 2022

2

N. L. Haigwood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

author name string

V. Planelles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

M. L. Marthas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

K. A. Mann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

C. Scandella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

W. D. Lidster

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

J. R. Shuster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

R. Van Kuyk

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

P. A. Marx

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

M. B. Gardner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760229

17 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1760229

17 November 2022

publication date

1 November 1991

1 reference

full work available at URL

7 November 2017

http://www.liebertpub.com/doi/pdf/10.1089/aid.1991.7.889

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

AIDS Research and Human Retroviruses

17 November 2022

published in

1 reference

7 November 2017

7

1 reference

7 November 2017

11

1 reference

7 November 2017

889-898

1 reference

describes a project that uses

7 November 2017

CHO-SIVmac239 gp130 Clone 3

0 references

cites work

Animal models of AIDS.

1

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

17 November 2022

3

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Simian immunodeficiency viruses

17 November 2022

5

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Identification of simian immunodeficiency virus SIVMAC env gene products

17 November 2022

7

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

The CD4 antigen: physiological ligand and HIV receptor

17 November 2022

8

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Molecular Biology and Medicine

17 November 2022

9

7

1

Bolognesi DP

1990

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Vaccine protection against simian immunodeficiency virus infection

17 November 2022

13

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

A formalin-inactivated whole SIV vaccine confers protection in macaques

17 November 2022

14

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Vaccine protection of rhesus macaques against simian immunodeficiency virus infection

17 November 2022

15

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine

17 November 2022

16

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

17 November 2022

18

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity

17 November 2022

20

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals

17 November 2022

23

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

17 November 2022

25

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

17 November 2022

27

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Antibody recognition of SIVmac envelope peptides in plasma from macaques experimentally infected with SIV/Mne.

17 November 2022

28

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study

17 November 2022

30

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals

17 November 2022

31

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

17 November 2022

32

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

17 November 2022

33

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies

17 November 2022

34

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120

17 November 2022

35

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody

17 November 2022

36

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160.

17 November 2022

37

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Vaccination against SIV infection and disease

17 November 2022

40

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14.

17 November 2022

41

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus

17 November 2022

42

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.889

17 November 2022

Identifiers

1 reference

7 November 2017

1 reference